Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese hormonally controlled FET cycles using OneCrinone for luteal support
jRCTs071180015Completed
- Sponsor
- Merck & Co.
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of progesterone in infertility, sponsored by Merck & Co. Primary endpoint: Clinical pregnancy rate per FET. Started May 2018; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on jRCTs071180015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180015.